
Treatment optimisation in mCRC: third line and beyond
Treatment of advanced colorectal cancer should be considered a continuum of care and patients should be offered as many life prolonging therapies as possible. Do you know how to sequence later line t...
11 Jan 202431min

Precision oncology: An overview of tumour agnostic therapies
What are tumour agnostic cancer treatments and which biomarkers do they target? Join Prof. David Hong (Medical Oncologist at MD Anderson Cancer Center, Houston, Texas, United States) and Dr Tracy L S...
7 Des 202322min

Prostate Cancer: Pre-Analytical Phase Challenges and Biomarker Testing
What are the common pre-analytical phase challenges in prostate cancer, and how can we overcome them? Why is it important to identify genetic alterations? You are listening to part 1 of a 3-part video...
6 Des 202329min



















